BioXcel Therapeutics Total Non Current Liabilities 2011-2026 | BTAI

Annual Total Non Current Liabilities BioXcel Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	1.4 M	1.03 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.4 M	1.03 M	1.21 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	326 M	$ 3.52	-1.26 %	$ 1.05 B	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	9.24 M	$ 3.22	2.88 %	$ 229 M	Schweiz
I-Mab IMAB	131 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	2.21 M	$ 0.8	1.81 %	$ 4.36 M	China
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	378 M	$ 4.13	-1.67 %	$ 105 M	Schweiz
argenx SE ARGX	226 M	$ 709.52	0.88 %	$ 25 B	Niderland
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.4	-5.82 %	$ 8.18 B	Australia
Ascendis Pharma A/S ASND	101 M	$ 228.5	-1.09 %	$ 5 B	Danmark
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	69.2 M	$ 6.1	0.83 %	$ 497 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 6.6	-0.45 %	$ 181 M	Israel
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	26.1 M	$ 14.52	1.11 %	$ 213 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
BioCardia BCDA	1.3 M	$ 1.3	2.36 %	$ 27.5 M	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.67	1.14 %	$ 16.8 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.49	-1.32 %	$ 380 M	Britain
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BioNTech SE BNTX	341 M	$ 92.62	2.3 %	$ 27.2 B	Germany
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Actinium Pharmaceuticals ATNM	682 K	$ 1.16	4.5 %	$ 34.9 M	USA